MedTrace Logo

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

NCT00407056 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-12-04

No results posted yet for this study

Summary

The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis.

Conditions

  • Uveitis
  • Panuveitis

Interventions

DRUG

Difluprednate Ophthalmic Emulsion

Sponsors & Collaborators

  • Sirion Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Shigeaki Ono · Department of Ophthalmology and Visual Science, Graduate School of Medicine, Hokkaido University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2003-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00407056 on ClinicalTrials.gov